Home > Boards > US Listed > Biotechs > iTeos Therapeutics, Inc. (ITOS)

ITOS~~MA200,@ $28.75,should break today here

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
ALERTS100%to10000%GAIN Member Profile
Member Level 
Followed By 1,022
Posts 77,650
Boards Moderated 66
Alias Born 03/10/09
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/16/2021 4:49:37 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/16/2021 4:47:45 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/13/2021 7:01:58 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/13/2021 7:00:20 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/8/2021 7:20:44 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/8/2021 7:14:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/8/2021 7:12:47 PM
iTeos Therapeutics to Participate in Upcoming September Investor Conferences GlobeNewswire Inc. - 9/1/2021 7:00:00 AM
iTeos Reports Second Quarter 2021 Financial Results and Provides Business Update GlobeNewswire Inc. - 8/12/2021 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/10/2021 7:00:55 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/5/2021 7:56:01 PM
iTeos to Report Second Quarter 2021 Financial Results and Provide Corporate Update on August 12, 2021 GlobeNewswire Inc. - 8/5/2021 7:00:00 AM
iTeos Therapeutics to Present at Wedbush PacGrow Healthcare Conference 2021 GlobeNewswire Inc. - 8/3/2021 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/28/2021 7:01:00 AM
iTeos Therapeutics to Present at William Blair Biotech Focus Conference 2021 GlobeNewswire Inc. - 7/8/2021 10:03:50 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/16/2021 6:49:25 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/16/2021 6:47:24 PM
GlaxoSmithKline - iTeos deal intensifies competition in anti-TIGIT space: Piper Sandler Seeking Alpha - 6/15/2021 9:51:27 AM
iTeos Therapeutics Shares Rise 32% on Deal With GlaxoSmithKline Dow Jones News - 6/14/2021 10:40:00 AM
GlaxoSmithKline, ITeos Therapeutics Team Up to Develop Immuno-Oncology Drug Dow Jones News - 6/14/2021 7:22:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/14/2021 7:16:20 AM
iTeos Therapeutics and GSK announce development and commercialisation collaboration for EOS-448, an anti-TIGIT monoclonal ant... GlobeNewswire Inc. - 6/14/2021 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/10/2021 5:35:54 PM
iTeos Therapeutics Announces New Phase 1/2a Data Indicating Antitumor Activity of inupadenant, its Adenosine A2A Receptor Ant... GlobeNewswire Inc. - 6/4/2021 9:00:00 AM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 6/3/2021 4:19:49 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences